CRAIG VINE: Open Payments
NPI 1164400495 · ST PAUL, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$439 in 13 payments from 9 companies in 2025. Trend: 2023 $34,542 · 2024 $16,505 · 2025 $439
Food & beverage: $439
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 3 | $199 |
| Neuronetics, Inc. | 1 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Alkermes, Inc. | 1 | $36 |
| Janssen Pharmaceuticals, Inc | 2 | $30 |
| Lundbeck LLC | 1 | $16 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA, LYBALVI, INVEGA SUSTENNA, REXULTI, FANAPT, LOREEV XR.
Industry payments across MN — which companies pay providers there.
